Security key
13463J101
Camp4 Therapeutics Corp - Common Stock, par value $0.0001 per share (CAMP)
CUSIP: 13463J101
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 12,854,057
- Total 13F value
- $67,096,861
- Share change
- +9,067,717
- SEC-reported price per share
- $5.22
- Number of holders
- 36
- Value change
- +$47,332,167
- Number of buys
- 34
- Shares outstanding
- 51,921,834
Holder snapshot
5 signals
Security identity
1 source field
Report period
Q4 2024
Institutions
36
Top holders
10
CAMP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Camp4 Therapeutics Corp SEC filings
Camp4 Therapeutics Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 13463J101
Recent filing periods:
Ownership snapshot
Top reported holders of CAMP - Camp4 Therapeutics Corp - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Enavate Sciences GP, LLC
Disclosed value leader
—
Comparable rows
0/4
Latest evidence
15 Oct 2024
3/4/5
Some rows are evidence-backed but not safely comparable across classes.
4 rows are not safely comparable across share classes.
Quick read
SEC ownership evidence is available, but the rows are not safely comparable across share classes.
0 of 4 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Detailed SEC evidence table Showing 1-4 of 4 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Enavate Sciences GP, LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
—
3,785,802 shares
|
— | 15 Oct 2024 |
| Northpond Ventures II GP, LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
—
2,238,244 shares
|
— | 15 Oct 2024 |
| AH Equity Partners Bio I, L.L.C. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
—
2,125,339 shares
|
— | 15 Oct 2024 |
| Polaris Partners GP X, L.L.C. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
—
909,090 shares
|
— | 15 Oct 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
36
Shares
12,854,057
Rows available
36
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q4 2025 Across Filers
Q4 2025 holders
39
Q4 2024 holders
36
Holder diff
-3
| Investor | Q4 2025 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q4 2025 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend